V. K. Viswanathan

2.7k total citations
65 papers, 2.1k citations indexed

About

V. K. Viswanathan is a scholar working on Infectious Diseases, Molecular Biology and Endocrinology. According to data from OpenAlex, V. K. Viswanathan has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 26 papers in Molecular Biology and 25 papers in Endocrinology. Recurrent topics in V. K. Viswanathan's work include Clostridium difficile and Clostridium perfringens research (23 papers), Escherichia coli research studies (18 papers) and Gut microbiota and health (15 papers). V. K. Viswanathan is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (23 papers), Escherichia coli research studies (18 papers) and Gut microbiota and health (15 papers). V. K. Viswanathan collaborates with scholars based in United States and Canada. V. K. Viswanathan's co-authors include Gayatri Vedantam, Gail Hecht, Michael Mallozzi, Nicholas P. Cianciotto, Jennifer Lising Roxas, Kim Hodges, Athanasia Koutsouris, Bryan Roxas, Michelle M. Merrigan and Dale N. Gerding and has published in prestigious journals such as Gastroenterology, PLoS ONE and Nature Reviews Microbiology.

In The Last Decade

V. K. Viswanathan

64 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. K. Viswanathan United States 26 973 865 630 354 242 65 2.1k
Tatsuo Yamamoto Japan 32 1.7k 1.8× 1.4k 1.7× 304 0.5× 392 1.1× 186 0.8× 151 3.1k
Yang Fu China 25 585 0.6× 692 0.8× 435 0.7× 214 0.6× 303 1.3× 67 2.0k
Olivia L. Champion United Kingdom 19 836 0.9× 1.3k 1.5× 320 0.5× 281 0.8× 352 1.5× 28 2.6k
Fabian Rivera-Chávez United States 12 764 0.8× 1.8k 2.1× 392 0.6× 167 0.5× 259 1.1× 17 2.6k
Daniel O. Sordelli Argentina 27 999 1.0× 979 1.1× 189 0.3× 255 0.7× 161 0.7× 117 2.3k
Tomoko Hanawa Japan 27 366 0.4× 691 0.8× 290 0.5× 337 1.0× 168 0.7× 66 1.9k
Franziska Faber Germany 17 768 0.8× 1.9k 2.2× 297 0.5× 177 0.5× 256 1.1× 31 2.6k
Mireia López‐Siles Spain 15 539 0.6× 1.5k 1.8× 198 0.3× 314 0.9× 446 1.8× 29 2.0k
Mary Ann De Groote United States 27 1.0k 1.0× 831 1.0× 202 0.3× 1.3k 3.5× 122 0.5× 34 3.2k
Ho Pan Sham Canada 24 644 0.7× 1.5k 1.7× 399 0.6× 193 0.5× 377 1.6× 29 2.7k

Countries citing papers authored by V. K. Viswanathan

Since Specialization
Citations

This map shows the geographic impact of V. K. Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. K. Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. K. Viswanathan more than expected).

Fields of papers citing papers by V. K. Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. K. Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. K. Viswanathan. The network helps show where V. K. Viswanathan may publish in the future.

Co-authorship network of co-authors of V. K. Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of V. K. Viswanathan. A scholar is included among the top collaborators of V. K. Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. K. Viswanathan. V. K. Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roxas, Jennifer Lising, et al.. (2025). CAT-GxD: Centralized access to gene expression datasets. Anaerobe. 96. 103005–103005.
2.
Lainhart, William, et al.. (2023). Prevalence of diagnostically-discrepant Clostridioides difficile clinical specimens: insights from longitudinal surveillance. Frontiers in Medicine. 10. 1238159–1238159. 1 indexed citations
3.
Maseda, Damián, Joseph P. Zackular, Bruno Caetano Trindade, et al.. (2019). Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response. mBio. 10(1). 43 indexed citations
4.
Roxas, Jennifer Lising & V. K. Viswanathan. (2018). Modulation of Intestinal Paracellular Transport by Bacterial Pathogens. Comprehensive physiology. 8(2). 823–842. 28 indexed citations
5.
Mallozzi, Michael, Bryan Roxas, Mário A. Monteiro, et al.. (2016). A Clostridium difficile Cell Wall Glycopolymer Locus Influences Bacterial Shape, Polysaccharide Production and Virulence. PLoS Pathogens. 12(10). e1005946–e1005946. 36 indexed citations
6.
Viswanathan, V. K.. (2014). Off-label abuse of antibiotics by bacteria. Gut Microbes. 5(1). 3–4. 115 indexed citations
7.
Viswanathan, V. K.. (2014). Muramyl dipeptide. Gut Microbes. 5(3). 275–375. 8 indexed citations
8.
Vedantam, Gayatri & V. K. Viswanathan. (2012). Leptin signaling protects the gut fromEntamoeba histolyticainfection. Gut Microbes. 3(1). 2–3. 12 indexed citations
9.
Viswanathan, V. K.. (2012). Sizing up microbes. Gut Microbes. 3(6). 483–484. 1 indexed citations
10.
Vedantam, Gayatri & V. K. Viswanathan. (2012). Naming names. Gut Microbes. 3(3). 173–175. 2 indexed citations
11.
Viswanathan, V. K.. (2011). Of cabbages and kings. Gut Microbes. 2(2). 67–68. 1 indexed citations
12.
Viswanathan, V. K., Michael Mallozzi, & Gayatri Vedantam. (2010). Clostridium difficileinfection. Gut Microbes. 1(4). 234–242. 84 indexed citations
13.
Viswanathan, V. K.. (2010). Eating in, eating out. Gut Microbes. 1(4). 207–208. 1 indexed citations
14.
Viswanathan, V. K.. (2010). Humor me. Gut Microbes. 1(2). 75–76. 1 indexed citations
15.
Bellmeyer, Amy, et al.. (2009). EnterohemorrhagicEscherichia colisuppresses inflammatory response to cytokines and its own toxin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 297(3). G576–G581. 24 indexed citations
16.
Viswanathan, V. K., Andrew W. Weflen, Athanasia Koutsouris, Jennifer Lising Roxas, & Gail Hecht. (2008). EnteropathogenicE. coli-induced barrier function alteration is not a consequence of host cell apoptosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 294(5). G1165–G1170. 23 indexed citations
17.
Viswanathan, V. K., Kim Hodges, & Gail Hecht. (2008). Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea. Nature Reviews Microbiology. 7(2). 110–119. 156 indexed citations
18.
Tesfay, Samuel, et al.. (2005). Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenicEscherichia colion intestinal epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(4). G685–G694. 57 indexed citations
19.
Viswanathan, V. K.. (2004). Microbes and their products—physiological effects upon mammalian mucosa. Advanced Drug Delivery Reviews. 56(6). 727–762. 11 indexed citations
20.
Viswanathan, V. K. & Gail Hecht. (2000). Innate immunity and the gut. Current Opinion in Gastroenterology. 16(6). 546–551. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026